We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4,690.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
24/1/2018 11:07 | SP does not make sense when you consider peers are trading on an average P/E of around 15 and this is closer to 9. Brokers clearly feel there should be no discount hence the 5000p-6000p targets. Bizarre. | justiceforthemany | |
24/1/2018 10:15 | It does seem as if no rise here will be tolerated for long. Ideal for trading though. | romeike | |
23/1/2018 10:23 | Buy those dips Sir, good capital upside from here imho parked in the ISA, long term hold. | ny boy | |
22/1/2018 23:44 | Shire to Present Data on Short Bowel Syndrome With Intestinal Failure at the ASPEN 2018 Nutrition Science & Practice Conference | philanderer | |
22/1/2018 22:39 | Shock for me was Sanofi paying that price. | essentialinvestor | |
22/1/2018 22:22 | Just read the Alphaville commentary. Those guys kind of talk in riddles and it's hard to tell what they're talking about or alluding to a lot of the time. Probably because they know their readers own the stocks and want any skerrick of bullish info, when they really don't have any more than anyone else, and are basically just as (mis)informed as the rest of us. | ruethewhirl | |
22/1/2018 22:04 | Bioverativ up 62% on the news... be nice to see a bit of that here lol | ruethewhirl | |
22/1/2018 15:31 | A bid from Pfizer might be welcome at the right price but I think Shire is perfectly capable of getting back to £50+ without bid rumours. | romeike | |
22/1/2018 13:48 | super, just need a username and email and you're in :-) "Martina Muttke, Head of International Medical Affairs at Shire, on what it takes to be a successful woman in pharma." | philanderer | |
22/1/2018 13:34 | super, it's free to read, just a simple registration. | essentialinvestor | |
22/1/2018 13:33 | Not a subscriber, can you copy and paste Phil? | superman21 | |
22/1/2018 13:30 | Sanofi acquiring Bioverativ for $11.6bn SHP mentioned here... | philanderer | |
22/1/2018 13:22 | $11.6 for Bioveratic!, No wonder SAN is selling off on the news. | essentialinvestor | |
22/1/2018 10:22 | 22nd jan Barclays equalweight tp 4000p | philanderer | |
22/1/2018 08:26 | Buy those dips Sir! | ny boy | |
19/1/2018 15:00 | Should be going up as £ is weakening. | philanderer | |
19/1/2018 14:43 | Volume has certainly picked up, the price is up and down around the 3500p mark like a yoyo right now. | romeike | |
19/1/2018 14:24 | Will our american friends take it down yet again ? | philanderer | |
19/1/2018 12:19 | A few closes over 3500p (support) would be encouraging | ny boy | |
19/1/2018 10:23 | I think hefty debt loads are par for the course right now, companies have taken advantage of ultra low rates and most are now looking to reduce those debts. Shire is doing a good job of paying down debt at the moment. I'd be more concerned about the debt if it was being ignored. | romeike | |
19/1/2018 08:48 | Reacting well to 3420p support, hopefully the bottom is in, defensive play with some upside will suit me, not really bothered about the divi, just parking some cash for a few years. | ny boy | |
19/1/2018 06:06 | Yield 0.71% so no good for income investors, perhaps write down coming for Bax division? Is that why shareprice falling? | montyhedge | |
18/1/2018 15:08 | Rome, had a scan of the sector over the last few days. Allergan has a hefty debt load, however owning Botox and Juvederm helps the cashflow!. They also developed Coolsculpt, which appears popular atm. Insider buying in the open market recently - I don't hold currently. | essentialinvestor | |
18/1/2018 14:19 | EI - funny you say that, I also suspect PFE will approach AGN. M & A activity is likely to increase after a long lull especially if there is more cash floating around. Shire looking more stable into the afternoon, hope it holds now. | romeike | |
18/1/2018 13:24 | 15% drop in 3 weeks | superman21 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions